{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:23:06Z","timestamp":1773264186371,"version":"3.50.1"},"reference-count":200,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01237","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:13:51Z","timestamp":1572534831000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacotherapy of Lower Respiratory Tract Infections in Elderly\u2014Focused on Antibiotics"],"prefix":"10.3389","volume":"10","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"B1","first-page":"17","article-title":"Peramivir (Rapivab): an IV neuraminidase inhibitor for treatment of influenza","volume":"57","year":"2015","journal-title":"Med. Lett. Drugs Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jama.2019.8199","article-title":"Omadacycline (Nuzyra)\u2013a new tetracycline antibiotic","volume":"322","year":"2019","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"3Rd","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S1198743X17303294","DOI":"10.1016\/j.cmi.2017.06.010","article-title":"New and improved? A review of novel antibiotics for gram-positive bacteria","volume":"23","author":"Abbas","year":"2017","journal-title":"Clin. Microbiol. Infect. Official Pub. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/srep31629","article-title":"Passive transfer of a germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal middle east respiratory syndrome coronavirus infection","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/srep44875","article-title":"Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein","volume":"7","author":"Al-Amri","year":"2017","journal-title":"Sci. Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijid.2013.12.003","article-title":"Ribavirin and interferon therapy in patients infected with the middle east respiratory syndrome coronavirus: an observational study","volume":"20","author":"Al-Tawfiq","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s40262-017-0623-4","article-title":"Clinical pharmacokinetics and pharmacodynamics of telavancin compared with the other glycopeptides","volume":"57","author":"Al Jalali","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e71375","DOI":"10.1371\/journal.pone.0071375","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in the Czech Republic, Hungary, Poland and Slovakia","volume":"8","author":"Ales","year":"2013","journal-title":"Plos One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1365-2125.2010.03631.x","article-title":"The recording of drug sensitivities for older people living in care homes","volume":"69","author":"Alldred","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/aje\/kwx001","article-title":"Influenza-associated hospitalizations for cardiovascular diseases in the tropics","volume":"186","author":"Ang","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1186\/s40064-015-1490-9","article-title":"Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with middle east respiratory syndrome coronavirus infection: a study protocol","volume":"4","author":"Arabi","year":"2015","journal-title":"Springerplus"},{"key":"B13","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1055\/s-0036-1592121","article-title":"Role of atypical pathogens in the etiology of community-acquired pneumonia","volume":"37","author":"Arnold","year":"2016","journal-title":"Semin Respir. Crit. Care Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jac\/dkn073","article-title":"Treatment costs associated with community-acquired pneumonia by community level of antimicrobial resistance","volume":"61","author":"Asche","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of middle east respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/cid\/ciu219","article-title":"A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia","volume":"59","author":"Awad","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"38069","DOI":"10.18632\/oncotarget.16971","article-title":"Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case report and review of the literature","volume":"8","author":"Bao","year":"2017","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","article-title":"Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)","volume":"16","author":"Barrera","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2217\/fmb.14.4","article-title":"The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia","volume":"9","author":"Barriere","year":"2014","journal-title":"Future Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212527","article-title":"How to manage Pseudomonas aeruginosa infections","volume":"7","author":"Bassetti","year":"2018","journal-title":"Drugs Context"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s40266-015-0320-7","article-title":"Erratum to: safety considerations of inhaled corticosteroids in the elderly","volume":"32","author":"Battaglia","year":"2015","journal-title":"Drugs Aging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1128\/AAC.48.2.546-555.2004","article-title":"Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression","volume":"48","author":"Bernardo","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.rmr.2018.01.002","article-title":"[Invasive pulmonary aspergillosis]","volume":"35","author":"Blanchard","year":"2018","journal-title":"Rev. Mal. Respir."},{"key":"B25","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1086\/428049","article-title":"Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides","volume":"40","author":"Blazquez Garrido","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B26","first-page":"487","article-title":"Dysregulated inflammation as a risk factor for pneumonia in the elderly","volume":"2","author":"Boyd","year":"2011","journal-title":"Aging Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.jinf.2013.09.016","article-title":"Which antibiotic for resistant gram-positives, and why","volume":"68","author":"Bradley","year":"2014","journal-title":"J. Infect."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1128\/AAC.01569-09","article-title":"Comparative in vitro antimicrobial activities of torezolid (TR-700), the active moiety of a new oxazolidinone, torezolid phosphate (TR-701), determination of tentative disk diffusion interpretive criteria, and quality control ranges","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/crj.12379","article-title":"Overview of antimicrobial options for mycoplasma pneumoniae pneumonia: focus on macrolide resistance","volume":"11","author":"Cao","year":"2017","journal-title":"Clin. Respir. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1128\/AAC.02972-14","article-title":"Safety, tolerability, and pharmacokinetics of intravenous nemonoxacin in healthy chinese volunteers","volume":"58","author":"Cao","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B31","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza \u2014 United States, 1976-2007","volume":"59","author":"Casey","year":"2010","journal-title":"MMWR Morb. Mortal Wkly Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging middle east respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J. Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1046\/j.1440-1843.2003.00522.x","article-title":"SARS: prognosis, outcome and sequelae","volume":"8","author":"Chan","year":"2003","journal-title":"Respirology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20050188","article-title":"SARS: clinical presentation, transmission, pathogenesis and treatment options","volume":"110","author":"Chan","year":"2006","journal-title":"Clin. Sci. (Lond.)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2147\/IDR.S193233","article-title":"The efficacy and safety of nemonoxacin compared with levofloxacin in the treatment of community-acquired pneumonia: a systemic review and meta-analysis of randomized controlled trials","volume":"12","author":"Chang","year":"2019","journal-title":"Infect. Drug Resist. Volume"},{"key":"B37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-017-0601-0","article-title":"Epidemiology of fungal infections in China","volume":"12","author":"Chen","year":"2018","journal-title":"Front. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/irv.12317","article-title":"Burden of influenza-associated deaths in the Americas, 2002-2008","volume":"9","author":"Cheng","year":"2015","journal-title":"Influenza Other Respir. Viruses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1016\/j.vaccine.2017.02.063","article-title":"DNA vaccine encoding middle east respiratory syndrome coronavirus S1 protein induces protective immune responses in mice","volume":"35","author":"Chi","year":"2017","journal-title":"Vaccine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.128.1.263","article-title":"Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers","volume":"128","author":"Chiou","year":"2005","journal-title":"Chest"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.2147\/CIA.S181400","article-title":"Impact of frailty on do-not-resuscitate orders and healthcare transitions among elderly Koreans with pneumonia","volume":"13","author":"Choi","year":"2018","journal-title":"Clin. Interv. Aging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"B43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0035-1562902","article-title":"Posaconazole: use in the prophylaxis and treatment of fungal infections","volume":"36","author":"Clark","year":"2015","journal-title":"Semin Respir. Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/cid\/cix740","article-title":"In- and out-of-hospital mortality associated with seasonal and pandemic influenza and respiratory syncytial virus in South Africa, 2009-2013","volume":"66","author":"Cohen","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1093\/jac\/dku167","article-title":"Pristinamycin: old drug, new tricks","volume":"69","author":"Cooper","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/15748847113089990062","article-title":"Multidrug-resistant gram-negative bacterial infections: are you ready for the challenge","volume":"9","author":"Curcio","year":"2014","journal-title":"Curr. Clin. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jac\/dkw428","article-title":"Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects","volume":"72","author":"Darpo","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/jac\/dkw428","article-title":"Solithromycin, a novel macrolide, does not prolong cardiac repolarization: a randomized, three-way crossover study in healthy subjects","volume":"72","author":"Darpo","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B49","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S2213-2600(17)30043-7","article-title":"Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies","volume":"5","author":"Darvishian","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2049936117690501","article-title":"Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens","volume":"4","author":"Das","year":"2017","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S0163-4453(17)30198-6","article-title":"Things that could be Mycoplasma pneumoniae","volume":"74","author":"de Groot","year":"2017","journal-title":"J. Infect."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4875","DOI":"10.1128\/AAC.03011-14","article-title":"Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture","volume":"58","author":"de Wilde","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1183\/13993003.00583-2015","article-title":"Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management","volume":"47","author":"Denning","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijid.2016.06.014","article-title":"Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis","volume":"49","author":"Ding","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","article-title":"Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials","volume":"385","author":"Dobson","year":"2015","journal-title":"Lancet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.vaccine.2016.12.011","article-title":"Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: a systematic review and meta-analysis","volume":"35","author":"Domnich","year":"2017","journal-title":"Vaccine"},{"key":"B57","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1060028018818094","article-title":"Omadacycline: A New Tetracycline Antibiotic","volume":"53","author":"Dougherty","year":"2019","journal-title":"Ann. Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S2213716517301248","DOI":"10.1016\/j.jgar.2017.03.018","article-title":"Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014)","volume":"10","author":"Duncan","year":"2017","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B59","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.3390\/ph12020063","article-title":"Omadacycline: a newly approved antibacterial from the class of tetracyclines","volume":"12","author":"Duraes","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/AAC.03036-14","article-title":"Repurposing of clinically developed drugs for treatment of middle east respiratory syndrome coronavirus infection","volume":"58","author":"Dyall","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jac\/37.1.117","article-title":"In-vitro activity of levofloxacin against clinical isolates of Legionella spp, its pharmacokinetics in guinea pigs, and use in experimental Legionella pneumophila pneumonia","volume":"37","author":"Edelstein","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-10-340","article-title":"European centre for disease prevention and control publishes annual epidemiological report 2011","volume":"16","year":"2011","journal-title":"Eur. Surveill"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1080\/14656566.2018.1516749","article-title":"Ceftobiprole medocaril for the treatment of community-acquired pneumonia","volume":"19","author":"Falco","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1128\/AAC.02465-14","article-title":"Ceftobiprole activity against over 60,000 clinical bacterial pathogens isolated in Europe, Turkey, and Israel from 2005 to 2010","volume":"58","author":"Farrell","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B66","article-title":"Efficacy and safety of IV-to-oral lefamulin, a pleuromutilin antibiotic, for treatment of community-acquired bacterial pneumonia: the phase 3 LEAP 1 trial","volume-title":"Clin. Infect. Dis.","author":"File","year":"2019"},{"key":"B67","doi-asserted-by":"publisher","first-page":"iii19","DOI":"10.1093\/jac\/dkr096","article-title":"FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia","volume":"66","author":"File","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/cid\/ciw490","article-title":"SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia","volume":"63","author":"File","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B69","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1001\/jama.1996.03530260048030","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia. a meta-analysis","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"B70","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1128\/AAC.00431-13","article-title":"In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions","volume":"57","author":"Flanagan","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cpdd.426","article-title":"Pharmacokinetics, safety, and tolerability of tedizolid phosphate in elderly subjects","volume":"7","author":"Flanagan","year":"2018","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"B72","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1055\/s-0037-1602715","article-title":"New strategies targeting virulence factors of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"38","author":"Francois","year":"2017","journal-title":"Semin Respir. Crit. Care Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/BF01700406","article-title":"Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia","volume":"16","author":"Genne","year":"1997","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B74","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1016\/j.vaccine.2017.04.085","article-title":"Rapid development of vaccines against emerging pathogens: the replication-deficient simian adenovirus platform technology","volume":"35","author":"Gilbert","year":"2017","journal-title":"Vaccine"},{"key":"B75","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1128\/AAC.01169-07","article-title":"Clinical and economic impact of common multidrug-resistant gram-negative bacilli","volume":"52","author":"Giske","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","article-title":"The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial","volume":"272","author":"Govaert","year":"1994","journal-title":"JAMA"},{"key":"B78","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00284-014-0622-8","article-title":"In vitro activity of new Cephalosporins vs Streptococcus pneumoniae from the Canadian bacterial surveillance network: 2008\u20132011","volume":"69","author":"Green","year":"2014","journal-title":"Curr. Microbiol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1185\/03007995.2013.825591","article-title":"Comparison of pharmacokinetics between new quinolone antibiotics: the zabofloxacin hydrochloride capsule and the zabofloxacin aspartate tablet","volume":"29","author":"Han","year":"2013","journal-title":"Curr. Med. Res. Opin."},{"key":"B80","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2169\/internalmedicine.46.6006","article-title":"Intravenous ciprofloxacin versus erythromycin in the treatment of Legionella pneumonia","volume":"46","author":"Haranaga","year":"2007","journal-title":"Intern. Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1099\/vir.0.061911-0","article-title":"Interferon-beta and mycophenolic acid are potent inhibitors of middle east respiratory syndrome coronavirus in cell-based assays","volume":"95","author":"Hart","year":"2014","journal-title":"J. Gen. Virol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/cid\/cix272","article-title":"Telavancin in the recent hospital acquired and ventilator associated pneumonia (HAP\/VAP) 2016 guidelines","volume":"64","author":"Hassoun","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2547","article-title":"Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments","volume":"348","author":"Heneghan","year":"2014","journal-title":"BMJ"},{"key":"B84","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.medmal.2016.10.004","article-title":"In vitro activity of ceftobiprole on 440 Staphylococcus aureus strains isolated from bronchopulmonary infections","volume":"47","author":"Hodille","year":"2017","journal-title":"Med. Mal. Infect."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"Hook","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B86","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/17425255.2017.1303481","article-title":"Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA","volume":"13","author":"Horn","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1128\/AAC.05354-11","article-title":"Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers","volume":"56","author":"Housman","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B88","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.diagmicrobio.2017.12.001","article-title":"Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe","volume":"90","author":"Huang","year":"2018","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3948626","article-title":"In vitro activity of iclaprim against methicillin-resistant Staphylococcus aureus nonsusceptible to Daptomycin, Linezolid, or Vancomycin: a pilot study","volume":"2017","author":"Huang","year":"2017","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.diagmicrobio.2018.09.002","article-title":"Surveillance of iclaprim activity: in vitro susceptibility of gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe","volume":"93","author":"Huang","year":"2019","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1473-3099(15)70070-8","article-title":"Corrections. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis","volume":"15","author":"Izurieta","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/s0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1016\/j.vaccine.2008.08.003","article-title":"Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program","volume":"26","author":"Jansen","year":"2008","journal-title":"Vaccine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10096-009-0727-3","article-title":"Nationwide surveillance of antimicrobial resistance among Haemophilus influenzae and Streptococcus pneumoniae in intensive care units in Taiwan","volume":"28","author":"Jean","year":"2009","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B95","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jmii.2017.01.001","article-title":"Corrigendum to \u201cRates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: results from the surveillance of multicenter antimicrobial resistance in Taiwan (SMART)\u201d","volume":"51","author":"Jean","year":"2017","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B96","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.diagmicrobio.2010.08.024","article-title":"Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY antimicrobial surveillance program (1998-2009)","volume":"68","author":"Jones","year":"2010","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1128\/AAC.00498-15","article-title":"Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects","volume":"59","author":"Justo","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B98","doi-asserted-by":"publisher","first-page":"e003912","DOI":"10.1136\/bmjopen-2013-003912","article-title":"Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis","volume":"3","author":"Kalil","year":"2013","journal-title":"BMJ Open"},{"key":"B99","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0924-977X(01)00100-6","article-title":"Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors","volume":"11","author":"Kasper","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1212\/01.WNL.0000046586.38284.60","article-title":"The effect of pneumonia on mortality among patients hospitalized for acute stroke","volume":"60","author":"Katzan","year":"2003","journal-title":"Neurology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2004.08.085","article-title":"In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine","volume":"323","author":"Keyaerts","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B102","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s40262-015-0281-3","article-title":"A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline","volume":"54","author":"Kiang","year":"2015","journal-title":"Clin. Pharmacokinet."},{"key":"B103","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based middle east respiratory syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"key":"B104","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12941-016-0150-4","article-title":"Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin","volume":"15","author":"Kocsis","year":"2016","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B105","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/QCO.0000000000000526","article-title":"New antibiotics for community-acquired pneumonia","volume":"32","author":"Kollef","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"B107","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijantimicag.2011.01.028","article-title":"In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology","volume":"38","author":"Kresken","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3201\/eid2008.140341","article-title":"Levofloxacin-resistant haemophilus influenzae, Taiwan, 2004-2010","volume":"20","author":"Kuo","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/jac\/dkl304","article-title":"In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent","volume":"58","author":"Kwon","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/mdr.2006.12.130","article-title":"Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan","volume":"12","author":"Lau","year":"2006","journal-title":"Microb. Drug Resist."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/jac\/dkm409","article-title":"In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action","volume":"60","author":"Laue","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B112","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcv.2004.07.006","article-title":"Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients","volume":"31","author":"Lee","year":"2004","journal-title":"J. Clin. Virol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1365-3156.2004.01281.x","article-title":"Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003","volume":"9","author":"Leong","year":"2004","journal-title":"Trop. Med. Int. Health"},{"key":"B114","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B115","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/myc.12645","article-title":"Cryptococcosis in patients with diabetes mellitus II in mainland China: 1993-2015","volume":"60","author":"Li","year":"2017","journal-title":"Mycoses"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1128\/AAC.01098-12","article-title":"Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model","volume":"57","author":"Liang","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B117","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/jac\/dkw206","article-title":"Characterization of the haematological profile of 21 days of tedizolid in healthy subjects","volume":"71","author":"Lodise","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"iii33","DOI":"10.1093\/jac\/dkr097","article-title":"FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia","volume":"66","author":"Low","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"B120","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1128\/AAC.00682-09","article-title":"Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers","volume":"54","author":"Luke","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/imj.12258","article-title":"Recurrent hospitalisation with pneumonia is associated with higher 1-year mortality in frail older people","volume":"43","author":"Ma","year":"2013","journal-title":"Intern. Med. J."},{"key":"B122","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B124","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1370\/afm.1993","article-title":"Prevalence of atypical pathogens in patients with cough and community-acquired pneumonia: a meta-analysis","volume":"14","author":"Marchello","year":"2016","journal-title":"Ann. Fam. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02158-18","article-title":"Low prevalence of gram-positive isolates showing elevated lefamulin MIC results during the SENTRY surveillance program for 2015-2016 and characterization of resistance mechanisms","volume":"63","author":"Mendes","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B127","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/jac\/7.3.217","article-title":"Erythromycin in legionnaires\u2019 disease: a re-appraisal","volume":"7","author":"Miller","year":"1981","journal-title":"J. Antimicrob. Chemother."},{"key":"B128","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21307\/pjm-2019-007","article-title":"In vitro and in vivo activity of Zabofloxacin and other Fluoroquinolones against MRSA isolates from a University Hospital in Egypt","volume":"68","author":"Mohamed","year":"2019","journal-title":"Pol. J. Microbiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.bbrc.2004.11.128","article-title":"Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines","volume":"326","author":"Morgenstern","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B130","doi-asserted-by":"publisher","first-page":"34s","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am. J. Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/cod.13084","article-title":"Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature","volume":"79","author":"Nespoulous","year":"2018","journal-title":"Contact Dermat."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJMoa025028","article-title":"Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly","volume":"348","author":"Nichol","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijantimicag.2011.11.005","article-title":"A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation","volume":"39","author":"Nicholson","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00103-010-1163-3","article-title":"Pandemic risk prevention in European countries: role of the ECDC in preparing for pandemics. Development and experience with a national self-assessment procedure, 2005-2008","volume":"53","author":"Nicoll","year":"2010","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B137","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14787210.2018.1489721","article-title":"Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa","volume":"16","author":"Ocheretyaner","year":"2018","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B138","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1128\/JVI.02448-13","article-title":"Inhibition of middle east respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody","volume":"87","author":"Ohnuma","year":"2013","journal-title":"J. Virol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe middle east respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"ii59","DOI":"10.1093\/jac\/dkh207","article-title":"Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studies","volume":"53","author":"Ortiz-Ruiz","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"B141","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijantimicag.2010.02.022","article-title":"DNA gyrase and topoisomerase IV are dual targets of zabofloxacin in Streptococcus pneumoniae","volume":"36","author":"Park","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B142","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"B143","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.amepre.2015.09.028","article-title":"Influenza-associated excess mortality in South Korea","volume":"50","author":"Park","year":"2016","journal-title":"Am. J. Prev. Med."},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02161-18","article-title":"Antibacterial activity of Lefamulin against pathogens most commonly causing community-acquired bacterial pneumonia: SENTRY antimicrobial surveillance program (2015-2016)","volume":"63","author":"Paukner","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/dmrr.682","article-title":"Common infections in diabetes: pathogenesis, management and relationship to glycaemic control","volume":"23","author":"Peleg","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B146","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s40477-017-0241-x","article-title":"Lung US features of severe interstitial pneumonia: case report and review of the literature","volume":"20","author":"Perrone","year":"2017","journal-title":"J. Ultrasound"},{"key":"B147","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/trstmh\/tru058","article-title":"The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review","volume":"108","author":"Peto","year":"2014","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01566-18","article-title":"Ceftobiprole activity against gram-positive and -negative pathogens collected from the United States in 2006 and 2016","volume":"63","author":"Pfaller","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00018-17","article-title":"Surveillance of omadacycline activity against clinical isolates from a global collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B150","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/INF.0000000000001477","article-title":"Ceftaroline activity tested against bacterial isolates causing community-acquired respiratory tract infections and skin and skin structure infections in pediatric patients from United States Hospitals: 2012-2014","volume":"36","author":"Pfaller","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02609-16","article-title":"In vitro activity of delafloxacin against contemporary bacterial pathogens from the United States and Europe, 2014","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B152","doi-asserted-by":"publisher","first-page":"A588","DOI":"10.1016\/j.jval.2014.08.2012","article-title":"A network meta-analysis comparing the efficacy and safety of Ceftobiprole and selected comparators in the treatment of hospital-acquired pneumonia","volume":"17","author":"Pooley","year":"2014","journal-title":"Value Health"},{"key":"B153","doi-asserted-by":"publisher","first-page":"101","DOI":"10.14336\/AD.2014.0500101","article-title":"Aging and injury: alterations in cellular energetics and organ function","volume":"5","author":"Poulose","year":"2014","journal-title":"Aging Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0002-9343(82)90511-3","article-title":"Infection and diabetes: the case for glucose control","volume":"72","author":"Rayfield","year":"1982","journal-title":"Am. J. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1128\/AAC.00212-10","article-title":"Use of pristinamycin for infections by gram-positive bacteria: clinical experience at an Australian hospital","volume":"54","author":"Reid","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2147\/COPD.S90948","article-title":"Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial","volume":"10","author":"Rhee","year":"2015","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/cid\/civ261","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans","volume":"61","author":"Richardson","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B158","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000487515","article-title":"Pseudomonas aeruginosa and Klebsiella pneumoniae adaptation to innate immune clearance mechanisms in the lung","volume":"10","author":"Riquelme","year":"2018","journal-title":"J. Innate. Immun."},{"key":"B159","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jac\/39.5.647","article-title":"In-vitro activity of dirithromycin against Chlamydia pneumoniae","volume":"39","author":"Roblin","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"B160","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1089\/mdr.2016.0021","article-title":"In vitro resistance development to Nemonoxacin in Streptococcus pneumoniae: a unique profile for a novel nonfluorinated quinolone","volume":"22","author":"Roychoudhury","year":"2016","journal-title":"Microb. Drug Resist."},{"key":"B161","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/ciq031","article-title":"Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens","volume":"52","author":"Rubinstein","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of Legionnaires disease","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"B163","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2217\/fmb.15.115","article-title":"Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia","volume":"10","author":"Scheeren","year":"2015","journal-title":"Future Microbiol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"e0170550","DOI":"10.1371\/journal.pone.0170550","article-title":"Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005 - 2016","volume":"12","author":"Schmid","year":"2017","journal-title":"PLoS One"},{"key":"B165","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ccm.2016.11.011","article-title":"Atypical pneumonia: updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia","volume":"38","author":"Sharma","year":"2017","journal-title":"Clin. Chest Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1093\/infdis\/jiw641","article-title":"Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US medicare beneficiaries in preventing Postinfluenza deaths during 2012-2013 and 2013-2014","volume":"215","author":"Shay","year":"2017","journal-title":"J. Infect. Dis."},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13286","article-title":"The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase","volume":"7","author":"Siala","year":"2016","journal-title":"Nat. Commun."},{"key":"B168","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5415\/apallergy.2017.7.4.185","article-title":"Respiratory allergies in the elderly: findings from the Korean longitudinal study on health and aging phase I study (2005-2006)","volume":"7","author":"Song","year":"2017","journal-title":"Asia Pac. Allergy"},{"key":"B169","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/0962-8924(92)90200-7","article-title":"Cyclophilins: a new family of proteins involved in intracellular folding","volume":"2","author":"Stamnes","year":"1992","journal-title":"Trends Cell Biol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa1800201","article-title":"Omadacycline for community-acquired bacterial pneumonia","volume":"380","author":"Stets","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1086\/510396","article-title":"Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus","volume":"195","author":"Stevens","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1128\/AAC.01429-10","article-title":"Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects","volume":"55","author":"Still","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B173","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01651-16","article-title":"Recombinant receptor-binding domains of multiple middle east respiratory Syndrome Coronaviruses (MERS-CoVs) induce cross-neutralizing antibodies against divergent human and camel MERS-CoVs and antibody escape mutants","volume":"91","author":"Tai","year":"2017","journal-title":"J. Virol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1128\/JVI.03001-13","article-title":"Blocking of exchange proteins directly activated by cAMP leads to reduced replication of middle east respiratory syndrome coronavirus","volume":"88","author":"Tao","year":"2014","journal-title":"J. Virol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1016\/j.vaccine.2012.06.086","article-title":"Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response","volume":"30","author":"Taylor","year":"2012","journal-title":"Vaccine"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/s1473-3099(17)30396-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Troeger","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B178","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1016\/j.vaccine.2013.07.059","article-title":"The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly","volume":"31","author":"Van Buynder","year":"2013","journal-title":"Vaccine"},{"key":"B179","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1128\/AAC.00295-10","article-title":"Efficacy and safety of nemonoxacin versus levofloxacin for community-acquired pneumonia","volume":"54","author":"van Rensburg","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B180","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1345\/aph.1Q074","article-title":"Role of rifampin-based combination therapy for severe community-acquired Legionella pneumophila pneumonia","volume":"45","author":"Varner","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/archinte.160.9.1294","article-title":"Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial","volume":"160","author":"Vergis","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"B182","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/phar.2166","article-title":"Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic","volume":"38","author":"Veve","year":"2018","journal-title":"Pharmacotherapy"},{"key":"B183","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0092-8674(03)00424-0","article-title":"mRNA cap-1 methyltransferase in the SARS genome","volume":"113","author":"von Grotthuss","year":"2003","journal-title":"Cell"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02008-16","article-title":"In vitro activities of Lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01734-16","article-title":"In vitro activities of Omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"60","author":"Waites","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B186","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","article-title":"Mycoplasma pneumoniae from the respiratory tract and beyond","volume":"30","author":"Waites","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"B187","doi-asserted-by":"publisher","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"B189","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-017-0584-z","article-title":"Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides","volume":"18","author":"Webley","year":"2017","journal-title":"Respir. Res."},{"key":"B190","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/0003-4819-70-4-689","article-title":"Recurrent pneumonia. Predisposing illness and clinical patterns in 158 patients","volume":"70","author":"Winterbauer","year":"1969","journal-title":"Ann. Intern. Med."},{"key":"B191","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1371\/journal.pmed.0030121","article-title":"Influenza-associated hospitalization in a subtropical city","volume":"3","author":"Wong","year":"2006","journal-title":"PLoS Med."},{"key":"B192","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03602.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013summary","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0012-3692(15)33412-7","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"B194","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s10096-006-0193-0","article-title":"Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit","volume":"25","author":"Yakovlev","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1111\/irv.12121","article-title":"Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China","volume":"7","author":"Yu","year":"2013","journal-title":"Influenza Other Respir. Viruses"},{"key":"B196","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jmii.2017.07.011","article-title":"Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: a phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial","volume":"52","author":"Yuan","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B197","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2147\/DDDT.S95934","article-title":"Effects of probenecid and cimetidine on the pharmacokinetics of nemonoxacin in healthy Chinese volunteers","volume":"10","author":"Zhang","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"B198","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(14)71018-7","article-title":"Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial","volume":"15","author":"Zhong","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"B199","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00108-004-1340-2","article-title":"Susceptibility of methicillin-resistant Staphylococcus aureus to vancomycin, teicoplanin, linezolid, pristinamycin and other antibiotics","volume":"7","author":"Zmira","year":"2005","journal-title":"Israel Med. Assoc. J."},{"key":"B200","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses - drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01237\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T15:13:56Z","timestamp":1572534836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01237\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":200,"alternative-id":["10.3389\/fphar.2019.01237"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01237","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"article-number":"1237"}}